MX2021015563A - Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes. - Google Patents

Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.

Info

Publication number
MX2021015563A
MX2021015563A MX2021015563A MX2021015563A MX2021015563A MX 2021015563 A MX2021015563 A MX 2021015563A MX 2021015563 A MX2021015563 A MX 2021015563A MX 2021015563 A MX2021015563 A MX 2021015563A MX 2021015563 A MX2021015563 A MX 2021015563A
Authority
MX
Mexico
Prior art keywords
negative
acid
gram
chp
fast bacteria
Prior art date
Application number
MX2021015563A
Other languages
English (en)
Spanish (es)
Inventor
Raymond Schuch
Original Assignee
Contrafect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contrafect Corp filed Critical Contrafect Corp
Publication of MX2021015563A publication Critical patent/MX2021015563A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14211—Microviridae
    • C12N2795/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2021015563A 2019-07-05 2020-07-02 Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes. MX2021015563A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962870908P 2019-07-05 2019-07-05
US201962892783P 2019-08-28 2019-08-28
US201962911900P 2019-10-07 2019-10-07
US201962948052P 2019-12-13 2019-12-13
US202062964743P 2020-01-23 2020-01-23
PCT/US2020/040714 WO2021007107A1 (en) 2019-07-05 2020-07-02 Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteria

Publications (1)

Publication Number Publication Date
MX2021015563A true MX2021015563A (es) 2022-03-17

Family

ID=74114204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015563A MX2021015563A (es) 2019-07-05 2020-07-02 Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.

Country Status (11)

Country Link
US (1) US20220401514A1 (cg-RX-API-DMAC7.html)
EP (1) EP3993821A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022539383A (cg-RX-API-DMAC7.html)
KR (1) KR20220029746A (cg-RX-API-DMAC7.html)
CN (1) CN114401735A (cg-RX-API-DMAC7.html)
AU (1) AU2020310107A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021025948A2 (cg-RX-API-DMAC7.html)
CA (1) CA3145990A1 (cg-RX-API-DMAC7.html)
IL (1) IL289412A (cg-RX-API-DMAC7.html)
MX (1) MX2021015563A (cg-RX-API-DMAC7.html)
WO (1) WO2021007107A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
WO2020139890A1 (en) * 2018-12-27 2020-07-02 Johnson & Johnson Consumer Inc. Device and method for selective application of topical composition using dynamic threshold values
KR20230047155A (ko) 2020-08-03 2023-04-06 존슨 앤드 존슨 컨수머 인코포레이티드 눈밑 브라이트닝을 부여하기 위한 화장 조성물의 선택적 도포용 시스템 및 방법
CA3213352A1 (en) * 2021-03-26 2022-09-29 Raymond Schuch Amurins, lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative bacteria
CN121445856B (zh) * 2025-10-24 2026-06-23 中国农业科学院生物技术研究所 溶菌酶及其衍生的抗菌肽和在制备抑菌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741697A (en) * 1995-11-30 1998-04-21 University Of Rochester Bacteriophage of chlamydia psittaci
CA2447823A1 (en) * 2001-05-23 2002-11-28 The University Of British Columbia Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation POLYPEPTIDE CONSTRUCTS WITH LYSINE ANTIMICROBIAL PEPTIDE (AMP), LYSINE, ISOLATED POLYNUCLEOTIDES ENCODING THEREOF AND USES THEREOF

Also Published As

Publication number Publication date
EP3993821A1 (en) 2022-05-11
CN114401735A (zh) 2022-04-26
BR112021025948A2 (pt) 2022-02-08
CA3145990A1 (en) 2021-01-14
IL289412A (en) 2022-02-01
US20220401514A1 (en) 2022-12-22
WO2021007107A1 (en) 2021-01-14
JP2022539383A (ja) 2022-09-08
EP3993821A4 (en) 2023-07-19
AU2020310107A1 (en) 2022-01-20
KR20220029746A (ko) 2022-03-08

Similar Documents

Publication Publication Date Title
MX2020010071A (es) Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
BR112021025948A2 (pt) Polipeptídeos antimicrobianos derivados de bacteriófagos e seu uso contra bactérias gram-negativas e ácido-resistentes
AU2016235147B2 (en) Antimicrobial peptides and methods of use thereof
EP3268023A2 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
JP2021508235A5 (cg-RX-API-DMAC7.html)
MX2020008860A (es) Lisinas plyss2 modificadas y sus usos.
JP2010534063A5 (cg-RX-API-DMAC7.html)
KR101896927B1 (ko) 흰점박이꽃무지에서 유래한 항균 펩타이드 프로테티아마이신 1 및 그의 조성물
US5235038A (en) Deletion and substitution analogues of melittin peptide
JP2017533177A5 (cg-RX-API-DMAC7.html)
WO2024256710A3 (en) Engineered lysin polypeptide constructs active against gram-negative bacteria
KR101889396B1 (ko) 흰점박이꽃무지에서 유래한 항균 펩타이드 프로테티아마이신 2 및 그의 조성물
CN108026155B (zh) 新抗微生物肽、它们的变体和用途
WO2024078645A3 (zh) Cas蛋白及其应用
JP2017522280A (ja) 特に獣医学分野用の消毒剤および抗微生物組成物
Chen et al. Antibacterial activity of short hydrophobic and basic-rich peptides
US20060258596A1 (en) Antimicrobial agents
CA2428662A1 (en) Small acid-soluble spore protein and uses thereof
WO2005021575A3 (en) Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
MX2020008677A (es) Novedoso bacteriofago de salmonella heidelberg sal-hep-1 y su uso para inhibir el crecimiento de las bacterias de salmonella heidelberg.
JP2005120050A (ja) 新規抗菌性ペプチドとその利用
KR100836596B1 (ko) 높은 염농도에서 항균 활성을 갖는 펩타이드들 및 이들을포함하는 항균 조성물
WO2002040529A3 (en) Diastereomeric peptides and pharmaceutical compositions comprising them
Kashyap Microbial metabolites: Peptides of diverse structure and function
JP2019510519A5 (cg-RX-API-DMAC7.html)